Insider Shareholders with Direct Ownership of Tyra Biosciences, Inc. (TYRA)
This section provides a comprehensive overview of the insiders with direct ownership of Tyra Biosciences, Inc. (TYRA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Tyra Biosciences, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
6,736,454 | 0 | 6,448,359 $94.8 Million | 2 |
Dec 17, 2021
Added 1.9%
|
|
Todd Harris
President and CEO |
95,766 | 402,175 | 1,355,927 $19.9 Million | 49 |
Oct 21, 2024
Reduced 0.96%
|
Canaan Xi L.P.
> 10% Shareholder |
4,409,991 | 0 | 473,396 $6.96 Million | 1 |
Sep 17, 2021
Added 50.0%
|
Daniel Bensen
Chief Operating Officer |
188,501 | 280,000 | 427,981 $6.29 Million | 67 |
Jun 10, 2024
Reduced 0.81%
|
Robert L. Hudkins
Chief Technology Officer |
3,448 | 0 | 273,576 $4.02 Million | 2 |
Sep 15, 2022
Added 0.38%
|
Ronald V. Swanson
Chief Scientific Officer |
3,125 | 0 | 273,254 $4.02 Million | 1 |
Mar 15, 2022
Added 1.13%
|
Isan Chen
Director |
61,444 | 0 | 192,783 $2.83 Million | 1 |
Sep 17, 2021
Added 24.17%
|
Esther Van Den Boom
Chief Financial Officer |
3,252 | 0 | 121,897 $1.79 Million | 2 |
Sep 15, 2022
Added 1.18%
|
61,392 | 0 | 89,623 $1.32 Million | 1 |
Jun 13, 2024
Added 40.65%
|
|
Hiroomi Tada
Chief Medical Officer |
8,513 | 0 | 86,435 $1.27 Million | 5 |
Mar 15, 2024
Added 2.23%
|
Piyush R. Patel
Chief Development Officer |
3,448 | 64,718 | 73,794 $1.08 Million | 4 |
Feb 21, 2023
Reduced 10.27%
|
0 | 265,568 | 22,527 $331,146 | 2 |
Feb 10, 2023
Reduced 74.43%
|
|
Alan Fuhrman
Chief Financial Officer |
12,849 | 0 | 12,849 $188,880 | 4 |
Oct 30, 2024
Added 42.51%
|